Ascopiave S.p.A.
ASCOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 42.9% | -3% | -6.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 91.6% | 91.7% | 98.5% | 93.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 49.5% | 139.6% | 52.5% | 52.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 14.2% | 105% | 16.9% | 17.2% |
| EPS Diluted | 0.05 | 0.26 | 0.043 | 0.047 |
| % Growth | -80.8% | 506.1% | -8.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |